BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36448195)

  • 1. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype.
    Kenney-Jung DL; Rogers DJ; Kroening SJ; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Gambardella ML; Contaldo I; Leoni C; Onesimo R; Zampino G; Tartaglia M; Battaglia DI; Pierpont EI
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):501-509. PubMed ID: 36448195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine.
    Snyder HE; Jain P; RamachandranNair R; Jones KC; Whitney R
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
    Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
    Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional vitamin B12 deficiency-associated Infantile epileptic spasms syndrome: Clinico-neurophysiological presentation, response to treatment, and neurodevelopmental outcome.
    Sharawat IK; Ramachandran A; Elwadhi A; Tomar A; Panda PK
    Seizure; 2023 Aug; 110():93-98. PubMed ID: 37331199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical Parvalbumin-Positive Interneuron Development and Function Are Altered in the APC Conditional Knockout Mouse Model of Infantile and Epileptic Spasms Syndrome.
    Ryner RF; Derera ID; Armbruster M; Kansara A; Sommer ME; Pirone A; Noubary F; Jacob M; Dulla CG
    J Neurosci; 2023 Feb; 43(8):1422-1440. PubMed ID: 36717229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.
    Nagarajan B; Gowda VK; Yoganathan S; Sharawat IK; Srivastava K; Vora N; Badheka R; Danda S; Kalane U; Kaur A; Madaan P; Mehta S; Negi S; Panda PK; Rajadhyaksha S; Saini AG; Saini L; Shah S; Srinivasan VM; Suthar R; Thomas M; Vyas S; Sankhyan N; Sahu JK
    Epilepsia Open; 2023 Dec; 8(4):1383-1404. PubMed ID: 37583270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study.
    Pierpont EI; Kenney-Jung DL; Shanley R; Zatkalik AL; Whitmarsh AE; Kroening SJ; Roberts AE; Zenker M
    Genet Med; 2022 Jul; 24(7):1556-1566. PubMed ID: 35524774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
    Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
    Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?
    Ng AC; Choudhary A; Barrett KT; Gavrilovici C; Scantlebury MH
    Epilepsia; 2024 Feb; 65(2):266-280. PubMed ID: 38036453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
    Prezioso G; Chiarelli F; Matricardi S
    Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Societal costs of illness for infantile epileptic spasms syndrome and evolutionary cost prediction in the era of WHO's IGAP.
    Bharti SK; Gupta I; Akshima ; Madaan P; Devi N; Dhir P; Negi S; Sankhyan N; Sahu JK; Bansal D
    Epilepsy Res; 2024 Jan; 199():107284. PubMed ID: 38159425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors influencing the efficacy of initial adrenocorticotropic hormone therapy for infantile epileptic spasms syndrome].
    Huang X; Peng J; Pan Z; Peng P; He F; Zhang CL; Chen C; Liu FY; Yin F; Mao LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):60-66. PubMed ID: 36655665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genotypes and phenotypes of IQSEC2 gene variants related epilepsy].
    Wang DH; Niu XY; Cheng MM; Chen Y; Yang Y; Yang XL; Yang ZX; Zhang YH
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1317-1321. PubMed ID: 36444437
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital readmissions in children with new-onset infantile epileptic spasms syndrome.
    Harini C; Yuskaitis CJ; Singh A; McHugh T; Liu S; DeLeo M; Gupta N; Marti C; Zhang B; Libenson MH; Berry JG
    Epilepsia Open; 2023 Jun; 8(2):444-455. PubMed ID: 36790214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brazilian experts' consensus on the treatment of infantile epileptic spasm syndrome in infants.
    Sampaio LPB; Henriques-Souza AMM; Silveira MRMD; Seguti L; Santos MLSF; Montenegro MA; Antoniuk S; Manreza MLG
    Arq Neuropsiquiatr; 2023 Sep; 81(9):844-856. PubMed ID: 37793406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome.
    Arai Y; Okanishi T; Kanai S; Ohta K; Sunada H; Noma H; Maegaki Y
    Epilepsy Behav; 2023 Aug; 145():109348. PubMed ID: 37459718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical mechanisms in pathogenesis of infantile epileptic spasm syndrome.
    Riikonen R
    Seizure; 2023 Feb; 105():1-9. PubMed ID: 36634586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of epilepsy in children with chromosomal aberration 47, XXY.
    Chen C; Luo Y; Hou X; Li T
    Brain Behav; 2023 Aug; 13(8):e3178. PubMed ID: 37479950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy in cardiofaciocutaneous syndrome: Clinical burden and response to anti-seizure medication.
    Kenney-Jung DL; Collazo-Lopez JE; Rogers DJ; Shanley R; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Pierpont EI
    Am J Med Genet A; 2024 Feb; 194(2):301-310. PubMed ID: 37827855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.